Sandu Pharmaceuticals Ltd 524703.BO

₹38.47 ₹0.96 (2.43%) 1D

Last Updated: May 15, 12:00 AM·BSE

524703.BO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 29, 2026

Report Source: 2026 2nd Quarter Report

Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Ltd. Stock Analysis 524703.BO

India Consumer Staples Nano Cap Report:
Sandu Pharmaceuticals Ltd. engages in the manufacture and marketing of Ayurvedic medicines. The company is headquartered in Mumbai, Maharashtra and currently employs 303 full-time employees. The firm's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The firm also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The firm's products are sold through e-commerce marketplaces.
Read More

Key Statistics of Sandu Pharmaceuticals Ltd (524703.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹38.00₹39.43

Today's Open

₹39.43

Volume

977.00

P/E Ratio (TTM)

24.07

52 Week Range

₹30.00₹58.80

Market Cap

358.01M

Avg. Volume

7381.45

Dividend Yield

2.07%

Financial Metrics & Statements of Sandu Pharmaceuticals Ltd (524703.BO)

Community-Curated Collections with Sandu Pharmaceuticals Ltd (524703.BO) ( With 524703.BO )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for Sandu Pharmaceuticals Ltd (524703.BO)

  • According to Musaffa’s Shariah screening methodology, Sandu Pharmaceuticals Ltd (524703.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.